Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Abbott Vascular Division of Abbott Australasia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (27)

Date

2020 (25)
2017 (2)

Results for "[search-keyword]"

Search

Sponsor content

27 result(s) found, displaying 21 to 27

Abbott Vascular Division of Abbott Australasia Pty Ltd - Catheter, angioplasty, balloon dilatation Cancelled under Section 41GL(d) of the Act

19 June 2020

Cancellation by sponsor

Requested by Abbott Vascular Division of Abbott Australasia Pty Ltd
Abbott Vascular Division of Abbott Australasia Pty Ltd - Hi-Torque Advance Guide Wires with Hydrocoat Hydrophilic Coating - Catheter guide wire Section 41GL(d) of the Act

31 March 2020

Cancellation by sponsor

Requested by Abbott Vascular Division of Abbott Australasia Pty Ltd
Abbott Vascular Division of Abbott Australasia Pty Ltd - Femoral Artery Closure Kit Section 41GL(d) of the Act

23 March 2020

Cancellation by sponsor

Requested by Abbott Vascular Division of Abbott Australasia Pty Ltd
Abbott Vascular Division of Abbott Australasia Pty Ltd - Suture/ligature implanting instrumentation, percutaneous Section 41GL(d) of the Act

23 March 2020

Cancellation by sponsor

Requested by Abbott Vascular Division of Abbott Australasia Pty Ltd
Abbott Vascular Division of Abbott Australasia Pty Ltd - Femoral artery suture implantation set Section 41GL(d) of the Act

23 March 2020

Cancellation by sponsor

Requested by Abbott Vascular Division of Abbott Australasia Pty Ltd
Abbott Vascular Division of Abbott Australasia Pty Ltd - XIENCE V Everolimus Eluting Coronary Stent - Stent, vascular, coronary artery Cancelled under s41GL(d) of the Act

13 September 2017

Cancellation by sponsor

Requested by Abbott Vascular Division of Abbott Australasia Pty Ltd
Abbott Vascular Division of Abbott Australasia Pty Ltd - ABSORB Bioresorbable Vascular Scaffold System - Biodegradable drug-eluting coronary artery stent Cancelled under s41GL(d) of the Act

18 April 2017

Cancellation by sponsor

Requested by Abbott Vascular Division of Abbott Australasia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Abbott Vascular Division of Abbott Australasia Pty Ltd

Type

Date

Abbott Vascular Division of Abbott Australasia Pty Ltd - Catheter, angioplasty, balloon dilatation Cancelled under Section 41GL(d) of the Act

Abbott Vascular Division of Abbott Australasia Pty Ltd - Hi-Torque Advance Guide Wires with Hydrocoat Hydrophilic Coating - Catheter guide wire Section 41GL(d) of the Act

Abbott Vascular Division of Abbott Australasia Pty Ltd - Femoral Artery Closure Kit Section 41GL(d) of the Act

Abbott Vascular Division of Abbott Australasia Pty Ltd - Suture/ligature implanting instrumentation, percutaneous Section 41GL(d) of the Act

Abbott Vascular Division of Abbott Australasia Pty Ltd - Femoral artery suture implantation set Section 41GL(d) of the Act

Abbott Vascular Division of Abbott Australasia Pty Ltd - XIENCE V Everolimus Eluting Coronary Stent - Stent, vascular, coronary artery Cancelled under s41GL(d) of the Act

Abbott Vascular Division of Abbott Australasia Pty Ltd - ABSORB Bioresorbable Vascular Scaffold System - Biodegradable drug-eluting coronary artery stent Cancelled under s41GL(d) of the Act

Help us improve the Therapeutic Goods Administration site